Search Results - "GRUTTERS, J. C"

Refine Results
  1. 1

    Potential interstitial lung abnormalities on chest X-rays prior to symptoms of idiopathic pulmonary fibrosis by Hoffman, T. W, van Es, H. W, Biesma, D. H, Grutters, J. C

    Published in BMC pulmonary medicine (30-08-2022)
    “…Abstract Background Idiopathic pulmonary fibrosis (IPF) often has significant diagnostic delay. At present it is not well-known what factors associate with…”
    Get full text
    Journal Article
  2. 2

    Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study by Moor, C. C, Mostard, R. L. M, Grutters, J. C, Bresser, P, Aerts, J. G. J. V, Dirksen, C. D, Kimman, M. L, Wijsenbeek, M. S

    Published in Respiratory research (23-07-2020)
    “…Abstract Background Two antifibrotic drugs, nintedanib and pirfenidone, are available for treatment of idiopathic pulmonary fibrosis (IPF). Although efficacy…”
    Get full text
    Journal Article
  3. 3

    [89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial by Adams, H., van de Garde, E. M. W., Vugts, D. J., Grutters, J. C., Oyen, Wim. J.G., Keijsers, R. G.

    “…Introduction Immune-mediated interstitial pneumonitis may be treated with anti-CD20 therapy after failure of conventional therapies. However, clinical response…”
    Get full text
    Journal Article
  4. 4

    Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis by Schimmelpennink, M. C, Meek, D. B, Vorselaars, A. D. M, Langezaal, L. C. M, van Moorsel, C. H. M, van der Vis, J. J, Veltkamp, M, Grutters, J. C

    Published in Respiratory research (25-06-2022)
    “…Abstract Background Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Corticosteroid treatment in sarcoidosis by Grutters, J. C, van den Bosch, J. M. M

    Published in The European respiratory journal (01-09-2006)
    “…At present there is no curative treatment for sarcoidosis. Immunosuppressive and/or immunomodulatory drugs can, however, be used for controlling the disease…”
    Get full text
    Journal Article
  7. 7

    Systemic cytokine response in patients with community-acquired pneumonia by ENDEMAN, H, MEIJVIS, S. C. A, RIJKERS, G. T, VAN VELZEN-BLAD, H, VAN MOORSEL, C. H. M, GRUTTERS, J. C, BIESMA, D. H

    Published in The European respiratory journal (01-06-2011)
    “…The role of individual cytokines and polymorphisms in pneumonia has been described, but the relationship between different cytokines and polymorphisms in…”
    Get full text
    Journal Article
  8. 8

    Septoplasty versus non-surgical management for nasal obstruction in adults with a deviated septum: economic evaluation alongside a randomized controlled trial by van Egmond, M M H T, Grutters, J P C, Hannink, G, van Heerbeek, N, Rovers, M M

    Published in BMC medicine (01-05-2020)
    “…For years, the benefits of septoplasty have been questioned. Due to the scarce and inconclusive literature, several National Health Service (NHS) Clinical…”
    Get full text
    Journal Article
  9. 9

    Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease by Fortunati, E, Kazemier, K. M, Grutters, J. C, Koenderman, L, Van den Bosch, Van J. M. M

    Published in Clinical and experimental immunology (01-03-2009)
    “…Summary Systemic inflammation can be investigated by changes in expression profiles of neutrophil receptors. Application of this technology for analysis of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Humoral Immune Status in Relation to Outcomes in Patients with Idiopathic Pulmonary Fibrosis by Hoffman, T. W., van Moorsel, C. H. M., Kazemier, K. M., Biesma, D. H., Grutters, J. C., van Kessel, D. A.

    Published in Lung (01-12-2021)
    “…Purpose Idiopathic pulmonary fibrosis (IPF) is a severe fibrotic lung disease, in which inflammation is thought to only play a secondary role. Several factors…”
    Get full text
    Journal Article
  12. 12

    Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study by Wijburg, C J, Michels, C T J, Oddens, J R, Grutters, J P C, Witjes, J A, Rovers, M M

    Published in BMC cancer (03-09-2018)
    “…Despite the fact that the cost-effectiveness of robot-assisted radical cystectomy (RARC) is not yet proven, and open radical (ORC) cystectomy is recommended as…”
    Get full text
    Journal Article
  13. 13

    Immunoglobulin A in serum: an old acquaintance as a new prognostic biomarker in idiopathic pulmonary fibrosis by ten Klooster, L., van Moorsel, C. H. M., Kwakkel‐van Erp, J. M., van Velzen‐Blad, H., Grutters, J. C.

    Published in Clinical and experimental immunology (01-08-2015)
    “…Summary Immunoglobulin (Ig)A is an important immunoglobulin in mucosal immunity and protects the lungs against invading pathogens. The production of IgA is…”
    Get full text
    Journal Article
  14. 14

    Change in Serum Biomarker CA 15-3 as an Early Predictor of Response to Treatment and Survival in Hypersensitivity Pneumonitis by Moll, S. A., Wiertz, I. A., Vorselaars, A. D. M., Ruven, H. J. T., van Moorsel, C. H. M., Grutters, J. C.

    Published in Lung (01-04-2020)
    “…Background Hypersensitivity pneumonitis (HP) is an interstitial lung disease with a heterogeneous course of disease and treatment response. Cancer antigen 15-3…”
    Get full text
    Journal Article
  15. 15

    Genetics of fibrosing lung diseases by Grutters, J. C, du Bois, R. M

    Published in The European respiratory journal (01-05-2005)
    “…Genetic studies in familial lung fibrosis have demonstrated an association with surfactant protein C genes: two mutations have been found resulting in protein…”
    Get full text
    Journal Article
  16. 16

    Genetic variability in the IL1RN gene and the balance between interleukin (IL)‐1 receptor agonist and IL‐1β in idiopathic pulmonary fibrosis by Barlo, N. P., van Moorsel, C. H. M., Korthagen, N. M., Heron, M., Rijkers, G. T., Ruven, H. J. T., van den Bosch, J. M. M., Grutters, J. C.

    Published in Clinical and experimental immunology (01-12-2011)
    “…Summary Idiopathic pulmonary fibrosis (IPF) is a rapidly progressive interstitial lung disease of unknown aetiology. Interleukin (IL)‐1β plays an important…”
    Get full text
    Journal Article
  17. 17

    Bronchoalveolar lavage cell pattern from healthy human lung by Heron, M., Grutters, J. C., ten Dam‐Molenkamp, K. M., Hijdra, D., van Heugten‐Roeling, A., Claessen, A. M. E., Ruven, H. J. T., van den Bosch, J. M. M., van Velzen‐Blad, H.

    Published in Clinical and experimental immunology (01-03-2012)
    “…Summary Bronchoalveolar lavage (BAL) is widely accepted as a key diagnostic procedure in interstitial lung diseases (ILD). We performed a study to obtain…”
    Get full text
    Journal Article
  18. 18

    Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis by Schimmelpennink, M C, Quanjel, M, Vorselaars, Adm, Wiertz, I, Veltkamp, M, Van Moorsel, Chm, Grutters, J C

    Published in Expert review of respiratory medicine (02-07-2020)
    “…Differentiating between interstitial lung diseases (ILD) is challenging. Serum soluble interleukin 2 receptor (sIL-2R) is used as a diagnostic marker in…”
    Get more information
    Journal Article
  19. 19

    Pulmonary hypertension complicating pulmonary sarcoidosis by Huitema, M. P., Grutters, J. C., Rensing, B. J. W. M., Reesink, H. J., Post, M. C.

    Published in Netherlands heart journal (01-06-2016)
    “…Pulmonary hypertension (PH) is a severe complication of sarcoidosis, with an unknown prevalence. The aetiology is multifactorial, and the exact mechanism of PH…”
    Get full text
    Journal Article
  20. 20

    The usefulness of repeated CMR and FDG PET/CT in the diagnosis of patients with initial possible cardiac sarcoidosis by Mathijssen, H., Tjoeng, T. W. H., Keijsers, R. G. M., Bakker, A. L. M., Akdim, F., van Es, H. W., van Beek, F. T., Veltkamp, M. V., Grutters, J. C., Post, M. C.

    Published in EJNMMI research (20-12-2021)
    “…Background Cardiac sarcoidosis (CS) diagnosis is usually based on advanced imaging techniques and multidisciplinary evaluation. Diagnosis is classified as…”
    Get full text
    Journal Article